Dépistage et diagnostic précoce des cancers chez les personnes vivant avec le VIH à l’ère des antirétroviraux : spécificités et enjeux

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Médecine et Maladies Infectieuses Formation

• Publication date

  2024-03-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.mmifmc.2024.01.004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.

  2022cited by this paper
• A systematic review and meta‐analysis of cytology and HPV‐related biomarkers for anal cancer screening among different risk groups

  2022cited by this paper
• Risk and incidence of head and neck cancers in veterans living with HIV and matched HIV‐negative veterans

  2022cited by this paper
• Incidence and mortality of non-AIDS-defining cancers among people living with HIV: A systematic review and meta-analysis

  2022cited by this paper
• Non-Melanoma Skin Cancer in People Living With HIV: From Epidemiology to Clinical Management

  2021cited by this paper
• [Recommendations of French specialists on screening for lung cancer].

  2021cited by this paper
• Deaths attributable to cancer in the United States HIV population during 2001-2015.

  2020cited by this paper
• Recurrence and Occurrence of Kaposi's Sarcoma in Patients Living With Human Immunodeficiency Virus (HIV) and on Antiretroviral Therapy, Despite Suppressed HIV Viremia.

  2020cited by this paper
• Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.

  2020cited by this paper
• Kaposi sarcoma in people living with HIV: a comparative study of classic and HIV-viremic and aviremic AIDS Kaposi Sarcoma.

  2020cited by this paper
• Primary HPV and Molecular Cervical Cancer Screening in US Women Living with HIV.

  2020cited by this paper
• A meta‐analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale

  2020cited by this paper
• Cervical cancer risk in women living with HIV across four continents: A multicohort study

  2019cited by this paper
• Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States

  2019cited by this paper
• Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial National Lung Screening Trial Writing Team 1.

  2019cited by this paper
• Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

  2019cited by this paper
• Cancer Risk in Older Persons Living With Human Immunodeficiency Virus Infection in the United States

  2018cited by this paper
• Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030

  2018cited by this paper
• The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status

  2018cited by this paper
• Spectrum of cancer risk among HIV-infected people in the United States during the modern antiretroviral therapy era: a population-based registry linkage study

  2017cited by this paper
• Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer

  2017cited by this paper
• Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis

  2017cited by this paper
• Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case‐control study in the Swiss HIV cohort study

  2016cited by this paper
• Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers

  2016cited by this paper
• Prevalence of and Risk Factors for Anal Oncogenic Human Papillomavirus Infection Among HIV-Infected Women in France in the Combination Antiretroviral Therapy Era.

  2016cited by this paper
• The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial.

  2016cited by this paper
• HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers

  2016cited by this paper
• Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected women.

  2016cited by this paper
• Incidence of cervical dysplasia and cervical cancer in women living with HIV in Denmark: comparison with the general population

  2016cited by this paper
• Cervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test.

  2015cited by this paper
• Incidence of cervical precancers among HIV-seropositive women.

  2015cited by this paper
• Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States

  2014cited by this paper
• Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

  2014cited by this paper
• Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: results from a French cohort

  2014cited by this paper
• Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort.

  2013cited by this paper
• Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis.

  2012cited by this paper
• Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

  2012cited by this paper
• Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection.

  2012cited by this paper
• HIV Infection, Immunodeficiency, Viral Replication, and the Risk of Cancer

  2011cited by this paper
• Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy

  2009cited by this paper
• Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta‐analysis

  2009cited by this paper
• Pattern of cancer risk in persons with AIDS in Italy in the HAART era

  2009cited by this paper
• Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.

  2007cited by this paper
• Trends in cancer risk among people with AIDS in the United States 1980–2002

  2006cited by this paper

• No citing papers are available for this paper.